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• Trichinosis, a re-emerging parasitic zoonotic disease, is a serious cause for 
concern in several countries.   
• The most common causative agent is, Trichinella spiralis, a nematode which can 
complete all stages of a life cycle within a single host.
• Trichinosis is most often caused by consumption of muscle encysted larvae in 
undercooked pork and exerts significant burden, both clinically and financially, 
on affected populations. Thus the need for affordable and safe preventative 
measures is imperative.
• Many current vaccines do not induce long term protective immunity and , those 
which are successful, are costly in manufacturing and distribution.
• Prior mucosal vaccine development studies have found that stimulating the gut 
immune system can induce long term protective immunity locally and 
systemically (Fujkuyama et al., 2012). 
• Many studies have focused on bioengineering probiotic bacteria as a delivery 
agent for vaccines.   However, prokaryotes lack the complex machinery required 
for efficient and correct folding of proteins in eukaryotes.
• Saccharomyces boulardii is a eukaryote and well characterized probiotic yeast. It 
is generally regarded as safe, known to modulate host immunity within the 
gastrointestinal tract (GIT) (Martins et al., 2009) and is almost genetically 
identical to baker’s yeast Saccharomyces cerevisiae.
• We are developing genetically modified (GMO) strains of S.boulardii as 
eukaryotic expression vectors for the delivery of mucosal vaccines to the GIT. 
Construct a GMO S.boulardii strain expressing protective antigens 
targeting T. spiralis creating mucosal vaccine.
• Synthesize a chimeric DNA molecule containing i) a-mating factor (aMF); a 
secretion factor ii) epitope tag – for detection of the recombinant protein iii) 
Trichinella antigen 1 or 2 ,and iiii) protein adjuvant – to increase the immune 
response thus inducing memory.  A cross-over PCR technique was employed.
• Clone into pGEM-T easy vector (Promega).
• Clone into the yeast expression vector pAC-TEF which will drive the expression 
of the chimeric protein with the strong constitutive TEF promoter.
•Individual products were first obtained using a typical PCR reaction at 50 degrees 
with appropriate forward and reverse primers used.
• Products linked using a crossover PCR reaction whereby templates were allowed 
to anneal in the absence of primers.  The length of this varied from 7-10 cycles 
dependent on the size of the templates being joined.
•Primers with homologous regions to both templates were added in the second 
PCR programme to generate a final product consisting of one long open reading 
frame (ORF) and restriction sites (see figure 1A).
•Recombinant DNA constructs were visualized by agarose gel electrophoresis.
•Products were gel extracted, a-tailed and ligated into pGEM -T Easy (see figure 
1B), transformed into XL1 blue cells and plated on LB agar with ampicillin, x-gal 
and IPTG for blue/white selection.  Colony screening and next generation 
sequencing confirmed the presence of the desired insert.
• DNA sequences from both the a-mating factor signal sequence/epitope tag and antigen were successfully 
joined using cross-over PCR (Figure 2) after various adjustments to a) number of PCR cycles, b) annealing 
temperature and c) extension time. 
• Optimum parameters for the initial crossover cycle were 10 cycles of annealing and extension with an 
annealing temperature of 52 degrees and extension time of 2 minutes.
• The protocol for joining the DNA sequences was principally empirical as there is a distinct lack of previous 
literature on the subject.  Published protocols focus on introducing mutations to the sequences by overlap 
extension PCR (Cha-Aim et al., 2012), however, this was used as a basis for the method.   
• Products generated by PCR were ligated into pGEM-T effectively (Figure 3) whereby colonies were 
screened by PCR using sequence specific primers (Figure 4.).
• The second antigen, although visible on a 1.5% gel at the correct size (not shown), could not be joined to 
• αmf/epitope-tag without a number of non-specific bands also being co-amplified and this is an issue that 
needs to be addressed in future work.
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• Sub-clone chimeric products into pAC8TEF, a yeast vector, for transformation into S.boulardii
• Detect expression of chimeric proteins using western blotting.
• Optimise expression of recombinant proteins using constitutive promoters. 
• Determine type of immune response to vaccine in GIT using immunoassays such as ELISA.
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Figure 1. (A) Construction of chimeric protein generated by cross-over PCR- sequences were joined together 
sequentially using a molar ratio of 1:1  (B) Vector map of pGEM-T showing restriction sites.
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Figure 2.  A, PCR product – chimeric DNA sequence at 1350bp, consistent with expected size.  Run on a 1.5% Agarose 
gel. B, Blue/white colonies plated on LB agar + ampicillin, X-gal and IPTG.  Transformed colonies containing insert are 
seen as white. C, Colonies positive for the final crossover insert in pGEM-T are seen above as bands at 1350 base pairs.  
Products were obtained using a Qiagen Plasmid mini prep and sent for sequencing using M13 forward and reverse primers.
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